<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03893331</url>
  </required_header>
  <id_info>
    <org_study_id>CLP-AF-006</org_study_id>
    <nct_id>NCT03893331</nct_id>
  </id_info>
  <brief_title>AcQMap® Global Registry of Procedural and Long-term Clinical Outcomes (AcQMap Registry)</brief_title>
  <acronym>DISCOVER</acronym>
  <official_title>AcQMap® Global Registry of Procedural and Long-term Clinical Outcomes (AcQMap Registry)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Acutus Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Acutus Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      AcQMap Registry is an observational study
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      AcQMap Registry is an observational, prospective, multi-center, multi-national, open-label
      registry designed to provide clinical data regarding the commercial, real-life experience
      with the diagnostic AcQMap System.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 13, 2019</start_date>
  <completion_date type="Anticipated">February 15, 2025</completion_date>
  <primary_completion_date type="Anticipated">August 15, 2024</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Procedural Ablation Outcomes</measure>
    <time_frame>12 hours</time_frame>
    <description>• Number of participants who had termination of ablated arrhythmia's to Sinus Rhythm within 12 hours post ablation procedure with or without electrical or pharmacological cardioversion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Long-term Outcome</measure>
    <time_frame>3 years</time_frame>
    <description>• First-procedure freedom from any arrhythmia on and/or off AADs, throughout the follow-up period, excluding events in the initial 90 days following the procedure (blanking period).</description>
  </secondary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Ablation of Arrhythmia's</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AcQMap System</intervention_name>
    <description>To evaluate procedural and long-term outcomes when using the diagnostic AcQMap System as an imaging and mapping system for ablation of arrhythmias in accordance with the Instructions for Use (IFU).</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Any participant 18 years of age or older. Currently scheduled for an ablation of an
        arrhythmia utilizing the diagnostic AcQMap System.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female 18 years of age or older.

          -  Currently scheduled for an ablation of an arrhythmia utilizing the diagnostic AcQMap
             System.

          -  Willingness, ability and commitment to participate in baseline and follow-up
             evaluations for the full length of the study.

          -  Willing and able to give written informed consent.

        Exclusion Criteria:

          -  In the opinion of the Investigator, any known contraindications to an ablation
             procedure.

          -  Current enrollment in any study protocol sponsored by Acutus Medical.

          -  Any other condition that, in the judgment of the investigator, makes the participant a
             poor candidate for this procedure, the study, or compliance with the protocol
             (includes vulnerable patient population, mental illness, addictive disease, extensive
             travel away from the research center, etc.).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Simon James, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>James Cook University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Steve McQuillan</last_name>
    <phone>7633314344</phone>
    <email>steven.mcquillan@acutus.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Deana Pierce</last_name>
    <phone>4422326087</phone>
    <email>deana.pierce@acutus.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Erasmus MC Cardiologie Elektrofysiologie</name>
      <address>
        <city>Rotterdam</city>
        <zip>3015 CE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tamas Szili-Torok, MD</last_name>
      <email>t.szilitorok@erasmusmc.nl</email>
    </contact>
    <contact_backup>
      <last_name>Petter Janse</last_name>
      <phone>+31 10 703 2700</phone>
      <email>p.janse@erasmusmc.nl</email>
    </contact_backup>
    <investigator>
      <last_name>Tamas Szili-Torok, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Papworth Hospital NHS Foundation Trust</name>
      <address>
        <city>Cambridge</city>
        <zip>CB38RE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew Grace, MD</last_name>
      <phone>44 1223 333 631</phone>
      <email>aag1000@cam.ac.uk</email>
    </contact>
    <contact_backup>
      <last_name>Rebecca McClean</last_name>
      <phone>44 1480 364 787</phone>
      <email>Rebecca.McClean@papworth.nhs.uk</email>
    </contact_backup>
    <investigator>
      <last_name>Andrew Grace, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Brompton Hospital</name>
      <address>
        <city>London</city>
        <zip>SW3 6NP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tom Wong, MD</last_name>
      <email>tom.wong@ic.ac.uk</email>
    </contact>
    <contact_backup>
      <last_name>Debra Dempster</last_name>
      <email>d.dempster@rbht.nhs.uk</email>
    </contact_backup>
    <investigator>
      <last_name>Tom Wong, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>James Cook University Hospital</name>
      <address>
        <city>Middlesbrough</city>
        <zip>TS4 3BW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simon James, MD</last_name>
      <phone>01642 282410</phone>
      <email>simon.james1@nhs.net</email>
    </contact>
    <contact_backup>
      <last_name>Deborah Athorne</last_name>
      <phone>01642 282410</phone>
      <email>deborah.athorne@nhs.net</email>
    </contact_backup>
    <investigator>
      <last_name>Simon James, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Freeman Hospital</name>
      <address>
        <city>Newcastle upon Tyne</city>
        <zip>NE7 7DN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ewen Shepherd, MD</last_name>
      <phone>7606379109</phone>
      <email>ewen.shepherd@nuth.nhs.uk</email>
    </contact>
    <contact_backup>
      <last_name>Ursula Harrison</last_name>
      <phone>44 191 213 7743</phone>
      <email>Ursula.Harrison@nuth.nhs.uk</email>
    </contact_backup>
    <investigator>
      <last_name>Ewen Shepherd, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>John Radcliffe Hospital</name>
      <address>
        <city>Oxford</city>
        <zip>OX3 9DU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tim Betts, MD</last_name>
      <phone>49 40 7410 52438</phone>
      <email>tim.betts@ouh.nhs.uk</email>
    </contact>
    <contact_backup>
      <last_name>Amy Hartley</last_name>
      <phone>44 1865 223 173</phone>
      <email>Amy.hartley@ouh.nhs.uk</email>
    </contact_backup>
    <investigator>
      <last_name>Tim Betts, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sheffield Teaching Hospital Northern General Hospital</name>
      <address>
        <city>Sheffield</city>
        <zip>S57AU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Justin Lee, MD</last_name>
      <email>Justin.lee@sth.nhs.uk</email>
    </contact>
    <contact_backup>
      <last_name>Charlotte Culver</last_name>
      <email>charlotte.culver@sth.nhs.uk</email>
    </contact_backup>
    <investigator>
      <last_name>Justin Lee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>March 26, 2019</study_first_submitted>
  <study_first_submitted_qc>March 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 28, 2019</study_first_posted>
  <last_update_submitted>June 11, 2020</last_update_submitted>
  <last_update_submitted_qc>June 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Arrhythmia's</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

